Median Technologies : Corporate Presentation and Webcast Replay – TD Cowen Health Care Conference – March 2024

Medical Imaging AI

Revolutionizing

• cancer patient diagnosis, treatment and survival
• cancer drug development

FREDRIK BRAG, CEO & FOUNDER

MEDIAN TECHNOLOGIES

TD COWEN 44TH HEALTH CARE CONFERENCE

BOSTON, MA, USA

MARCH 4-6, 2024

Applying AI and computer vision, we help conquer cancer and other life-threatening diseases by extracting powerful clinical insights from medical images.

Our people	260+ highly qualified professionals in the
	US, Europe and China, 25+ nationalities
	(As of Dec. 31, 2023).
Our growth	Powered by proprietary AI, computer
	vision and signal processing technologies,
	strong KOL connections, and medical,
	scientific, technology partnerships.
	With eyonis , our AI/ML tech-based
	suite of software as medical devices
	(SaMD), we help enable clinicians to
	diagnose patients earlier.
Imaging	Our iCRO imaging solutions and advanced
Lab	Imaging Lab offer help our 80+
	biopharma clients drive their oncology
	clinical studies toward successful
	approval, using AI-driven image insights.

Imaging AI for Cancer

3	mediantechnologies.com | TD Cowen 44th Health Care Conference | March 4-6, 2024 | Boston, MA, USA

Imaging AI for Patient Care

Imaging AI for Patient Care is revolutionizing preventive care and will help eradicate cancer by:

• Fueling the emergence of early diagnosis,
• Allowing predictive and personalized treatment plans,
• Leading to better patient outcomes.

4	mediantechnologies.com | TD Cowen 44th Health Care Conference | March 4-6, 2024 | Boston, MA, USA

AI in Drug Discovery & Development

Based on data-driven insights, AI technologies will enable personalized treatments for better outcome:

• By decreasing the number of compounds subsequently tested in pre-clinical and clinical studies (clinical trials),
• By enabling personalized treatments,
• By helping the biopharma industry control at best the drug development process, time and costs.

5	mediantechnologies.com | TD Cowen 44th Health Care Conference | March 4-6, 2024 | Boston, MA, USA

The Global Cancer Burden

Imaging AI will have the biggest impact ever on cancer care

6	mediantechnologies.com | TD Cowen 44th Health Care Conference | March 4-6, 2024 | Boston, MA, USA

Facts & Trends about Cancer

Financial burden of

1 cancer in the US was $210bn in 2020 and projected to exceed $245bn by 2030 [1].

The cost for bringing a

4 cancer drug to market is $2.7Bn [2] during 12 years. With AI it could be a fraction of the cost & time

97% of cancer care

2 money goes for treatment of sick patients vs 3% for preventive care.

5	The cost of developing a
new AI based imaging

diagnostic test for cancer is approx. $40m.

3

6

Most Stage 1 cancer can be cured and can now be identified with Imaging AI.

Most cancer drugs could become curative through personalized treatments. Viral Therapy, vaccine & immune therapy

		Sources:
		[1]	American Association for Cancer Research
7	mediantechnologies.com | TD Cowen 44th Health Care Conference | March 4-6, 2024 | Boston, MA, USA	[2]	Deloitte Report - January 2023

US Cancer Death Rates Evolution over the Long-run

Early diagnosis and lifestyles changes have the biggest impact on cancer death rates:

• Lung and stomach cancer death rates decrease, driven by lifestyles changes.

• Prostate, colorectal and breast cancer rates decrease, driven by early diagnosis and screening programs.

8	mediantechnologies.com | TD Cowen 44th Health Care Conference | March 4-6, 2024 | Boston, MA, USA

AI Breakthroughs Applied to Medical Imaging Mark the Beginning of a New Era for Cancer Management

Applying AI and computer vision technologies help conquer cancer by extracting powerful clinical insights from medical images.

1|	2|	3|	Guide health
professionals in
Diagnose			their clinical
cancer earlier		Personalize
	decision-making
and more		treatments
	with data-

accurately	driven clinical
	insights

9	mediantechnologies.com | TD Cowen 44th Health Care Conference | March 4-6, 2024 | Boston, MA, USA

Median Technologies Leverages AI Technologies to Bring More Value to Medical Images all along the Patient Journey

Adding more	Generating more	Providing more
AI-driven data
value to oncology	accurate
for oncology
trials	AI-driven diagnosis
drug development

•	Extract drug efficacy data	•	Select early-stage patient		•	Develop noninvasive, early-
•	Streamline the clinical	•	Discover predictive			stage diagnostic solutions
	process		imaging biomarkers		•	Market SaMDs for routine
							clinical use
						•	Develop companion diagnostics

10 mediantechnologies.com | TD Cowen 44th Health Care Conference | March 4-6, 2024 | Boston, MA, USA